Markets Wane, Softbank Down about 5%
Asia-Pacific markets closed lower Tuesday, tracking Wall Street declines overnight ahead of the U.S. Federal Reserve meeting later this week.
Investors also assessed the talks between U.S. President Donald Trump, Ukraine’s President Volodymyr Zelenskyy and European leaders at the White House, aimed at stopping the Moscow-Kyiv conflict.
In Japan, the Nikkei ditched 168.02 points, or 0.4%, to 43,546.29
In Hong Kong, the Hang Seng retreated 53.95 points, or 0.2%, to 25,122,90.
Investment firm SoftBank Group snapped its nine-day winning streak Tuesday after its shares plunged over 5% following its announcement of a $2 billion investment in Intel. As part of the deal, SoftBank will pay $23 per share for Intel’s common stock, which closed at $23.66 on Monday.
In other markets
In Shanghai, the CSI 300 handed over 16.04 points, or 0.4%, to 4,223.37.
In Singapore, the Straits Times index recovered 28.81 points, or 0.7%, to 4,216.19
In Korea, the Kospi lost 25.72 points, or 0.8%, to 3,151.56.
In Taiwan, the Taiex index faded 76 points, or 0.4%, to 24,114.87.
In New Zealand, the NZX 50 dipped 41.96 points, or 0.3%, to 12,928.68
In Australia, the ASX 200 subtracted 63.11 points, or 0.7%, to 8,896.16
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


